These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 9001162)

  • 41. Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses.
    Zhou J; Ma X; Wang T; Zhai S
    Osteoporos Int; 2016 Nov; 27(11):3289-3300. PubMed ID: 27273112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risedronate for prevention and treatment of osteoporosis in postmenopausal women.
    Recker RR; Barger-Lux J
    Expert Opin Pharmacother; 2005 Mar; 6(3):465-77. PubMed ID: 15794737
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis.
    Halasy-Nagy JM; Rodan GA; Reszka AA
    Bone; 2001 Dec; 29(6):553-9. PubMed ID: 11728926
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bisphosphonates in prostate carcinoma.
    Adami S
    Cancer; 1997 Oct; 80(8 Suppl):1674-9. PubMed ID: 9362435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Etidronate and alendronate in the treatment of postmenopausal osteoporosis.
    Beauchesne MF; Miller PF
    Ann Pharmacother; 1999 May; 33(5):587-99. PubMed ID: 10369624
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence based medicine and effective interventions of pharmacological therapy for the prevention of osteoporotic fractures.
    Cesareo R; Iozzino M; Alva D; Napolitano C; De Rosa B; Contini S; Mallardo L; Lauria A; Reda G; Orsini A
    Minerva Endocrinol; 2007 Dec; 32(4):275-95. PubMed ID: 18091664
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of bisphosphonates in the treatment of osteoporosis.
    Delmas PD
    Curr Opin Rheumatol; 2005 Jul; 17(4):462-6. PubMed ID: 15956844
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bisphosphonates in the treatment of osteoporosis.
    Bell NH; Johnson RH
    Endocrine; 1997 Apr; 6(2):203-6. PubMed ID: 9225137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanism of action of bisphosphonates.
    Reszka AA; Rodan GA
    Curr Osteoporos Rep; 2003 Sep; 1(2):45-52. PubMed ID: 16036064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.
    Harris ST; Watts NB; Genant HK; McKeever CD; Hangartner T; Keller M; Chesnut CH; Brown J; Eriksen EF; Hoseyni MS; Axelrod DW; Miller PD
    JAMA; 1999 Oct; 282(14):1344-52. PubMed ID: 10527181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term treatment of osteoporotic women with bisphosphonates does not impair the response to subsequently administered intravenous pamidronate.
    Yavropoulou MP; Hamdy NA; Papapoulos SE
    Osteoporos Int; 2013 Aug; 24(8):2353-7. PubMed ID: 23436076
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Summaries for patients. Drug therapy for osteoporosis.
    Ann Intern Med; 2008 May; 148(9):I28. PubMed ID: 18458273
    [No Abstract]   [Full Text] [Related]  

  • 53. Determinants of change in bone mineral density and fracture risk during bisphosphonate holiday.
    Xu LH; Adams-Huet B; Poindexter JR; Maalouf NM
    Osteoporos Int; 2016 May; 27(5):1701-8. PubMed ID: 26642963
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bisphosphonates.
    Lambrinoudaki I; Christodoulakos G; Botsis D
    Ann N Y Acad Sci; 2006 Dec; 1092():397-402. PubMed ID: 17308164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Osteoporosis: trials and tribulations.
    Seeman E
    Am J Med; 1997 Aug; 103(2A):74S-87S; discussion 87S-89S. PubMed ID: 9302899
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Fluorides and bisphosphonates in the treatment of osteoporosis].
    Ringe JD
    Orthopade; 2001 Jul; 30(7):456-61. PubMed ID: 11515184
    [TBL] [Abstract][Full Text] [Related]  

  • 57. When do bisphosphonates make the most sense?
    Winzenberg T; Jones G
    J Fam Pract; 2011 Jan; 60(1):18-28. PubMed ID: 21209974
    [No Abstract]   [Full Text] [Related]  

  • 58. BM 21.0955, a potent new bisphosphonate to inhibit bone resorption.
    Mühlbauer RC; Bauss F; Schenk R; Janner M; Bosies E; Strein K; Fleisch H
    J Bone Miner Res; 1991 Sep; 6(9):1003-11. PubMed ID: 1838661
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical effects of bisphosphonates in involutional osteoporosis.
    Ott SM
    J Bone Miner Res; 1993 Dec; 8 Suppl 2():S597-606. PubMed ID: 8122531
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bisphosphonate treatment of osteoporosis.
    Watts NB
    Clin Geriatr Med; 2003 May; 19(2):395-414. PubMed ID: 12916293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.